CALL US:022-6101 1710   sales@saffronmedia.in
HOME NEWS INGREDIENT MART EVENTS TOPICS INTERVIEW EDIT
 

ARCHIVES FOR THE MONTH OF JANUARY - 2024
 
Indian pharma eyes ease of shared regulatory frameworks and quality standards for its foray into nutraceuticals
TN PMA asks state govt to approach Central govt to provide 3-year time to implement Revised Schedule M
DGTR to hold oral hearing in the anti-dumping investigation case of epichlorohydrin on Feb 8, 2024
Over 86% of NPPA's total demand against overcharging yet to be recovered
Healthcare experts unveil wishlist for budget with focus on infrastructure, tax incentives & GST reduction
WB pharma SSIs demand more time & financial assistance from govt to implement revised Schedule M
Bangladesh API Park offers immense potential for Indian API industry through JVs, technology tie-ups
Exports to be badly hit as freight rates increase by 100% to 150% as shipping carriers change route
CDSCO launches National Single Window System portal aiming at developing it as one-stop-shop for all approvals
Indian pharma credits its success on patient trust in the medicines it manufactures: Jatish Sheth
Experts hail proposed draft Schedule M guidelines placing emphasis on stability testing
In 2024, industry to focus on strengthening digital tech implementation and regulatory changes
2024 a landmark year for Indian pharma with advancements in manufacturing, tech & healthcare access
Parliamentary panel asks DoP to take up issues related to schemes with state agencies
Parliamentary Panel recommends Centre to include provisions from Obamacare into Ayushman Bharat
  • |
  • Current Page :
Back
 
INGREDIENT MART

RECENT NEWS

TOPICS
That foods might provide therapeutic benefits is clearly not a new concept. ...

 

MAIN LINKS OUR SERVICES OTHER PRODUCTS ONLINE MEDIA  
 
About Us
Contact Us
News Archives
 

Product Finder
Features and Articles
News
 
Chronicle Pharmabiz
Food & Bevergae News
Ingredients South Asia
 
Media Information
Rate Card
Advertise
 
 
Copyright © 2023 Saffron Media Pvt Ltd. All Rights Reserved.
Best View in Chrome (103.0) or Firefox (90.0)